Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Taizhou project for preventing mother-to-child hepatitis B transmission with different tenofovir start times
ChiCTR1800017932Phase 4Not yet recruiting
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tenofovir disoproxil fumarate in hepatitis B (HBV) (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Rate of HBV mother-to-child transmission, Maternal HBV-DNA decline rate and 6 more. Planned start Nov 2018; status: not yet recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on ChiCTR1800017932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017932.